A molecule produced by gut bacteria can trigger heart disease, according to research published in Nature. Scientists at ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has made two additions to its ...

The Philippine Lipid and Atherosclerosis Society (PLAS) led a call to action on managing dyslipidemia during the recent ...

The discovery, made thanks to an experiment involving hundreds of bank employees in Spain, opens the door to new treatments ...

Researchers at the University of Pittsburgh found that repeatedly consuming high-protein diets could lead to issues with ...

ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune activation and inflammation.

Current dietary guidelines suggest protein should make up 10 to 35 per cent of daily calories, with the American Heart ...

Cardiovascular disease is the leading cause of death worldwide and often originates in atherosclerosis, a chronic condition in which inflammation and fat deposits cause arteries to harden and narrow.

A CNIC-led study has identified imidazole propionate, a metabolite produced by gut bacteria, as a driver of atherosclerosis—a ...

A bacterially produced molecule circulates in the bloodstream and increases the risk of cardiovascular disease by hijacking ...

We're delighted to announce $6.5 million in philanthropic investments from the Colonial Foundation and philanthropist, David Russell, to supercharge ...

Pfizer Inc. has identified signal transducer and activator of transcription 6 (STAT6) inhibitors reported to be useful for the treatment of Alzheimer’s disease, cancer, atherosclerosis, metabolic ...